Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Multi-omics analyses reveal novel effects of PLCγ2 deficiency in the mouse brain.
bioRxiv [Preprint]. 2023 Dec 8:2023.12.06.570499. doi: 10.1101/2023.12.06.570499.
bioRxiv. 2023.
PMID: 38106102
Free PMC article.
Preprint.
The interactions between patient preferences, expectancies, and stigma contribute to posttraumatic stress disorder treatment outcomes.
Moring JC, Peterson AL, Straud CL, Ortman J, Mintz J, Young-McCaughan S, McGeary CA, McGeary DD, Litz BT, Macdonald A, Roache JD, Resick PA, For The Strong Star Consortium.
Moring JC, et al.
J Trauma Stress. 2023 Dec;36(6):1126-1137. doi: 10.1002/jts.22982. Epub 2023 Oct 26.
J Trauma Stress. 2023.
PMID: 37883128
Free PMC article.
Clinical Trial.
Item in Clipboard
PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.
Yang X, Liu Z, Tang W, Pratap UP, Collier AB, Altwegg KA, Gopalam R, Li X, Yuan Y, Zhou D, Lai Z, Chen Y, Sareddy GR, Valente PT, Kost ER, Viswanadhapalli S, Vadlamudi RK.
Yang X, et al.
Mol Oncol. 2023 Oct 19. doi: 10.1002/1878-0261.13539. Online ahead of print.
Mol Oncol. 2023.
PMID: 37853941
Free article.
Item in Clipboard
Redox status regulates autophagy in thymic stromal cells and promotes T cell tolerance.
Semwal MK, Hester AK, Xiao Y, Udeaja C, Cepeda S, Verschelde JS 2nd, Jones N, Wedemeyer SA, Emtage S, Wimberly K, Griffith AV.
Semwal MK, et al.
Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2204296119. doi: 10.1073/pnas.2204296119. Epub 2022 Sep 26.
Proc Natl Acad Sci U S A. 2022.
PMID: 36161925
Free PMC article.
Item in Clipboard
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.
Altwegg KA, Viswanadhapalli S, Mann M, Chakravarty D, Krishnan S, Liu Z, Liu J, Pratap UP, Ebrahimi B, Sanchez JR, Li X, Ma S, Park BH, Santhamma B, Chen Y, Lai Z, Raj GV, Yuan Y, Zhou D, Sareddy GR, Tekmal RR, McHardy S, Huang TH, Rao MK, Vankayalapati H, Vadlamudi RK.
Altwegg KA, et al.
Cancer Res. 2022 Oct 17;82(20):3830-3844. doi: 10.1158/0008-5472.CAN-22-0698.
Cancer Res. 2022.
PMID: 35950923
Free PMC article.
Item in Clipboard
Cite
Cite